A phase II study of spirogermanium in patients with metastatic malignant melanoma. An NCI Canada Clinical Trials Group Study. (Q54124863)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase II study of spirogermanium in patients with metastatic malignant melanoma. An NCI Canada Clinical Trials Group Study. |
scientific article |
Statements
A phase II study of spirogermanium in patients with metastatic malignant melanoma. An NCI Canada Clinical Trials Group Study. (English)
E Eisenhauer
I Kerr
A Bodurtha
N Iscoe
P McCulloch
K Pritchard
I Quirt
1 January 1985
3
3
303-305
1 reference